Glucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis
Daisuke Miura, Stephen Nicholls, Anju E Joham, Michael Braude, Chau Thien Tay · 2026
Read Glucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis by Daisuke Miura, Stephen Nicholls, Anju E Joham, Michael Braude, Chau Thien Tay (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13579051.txt.
Description
Extremely high triglycerides can inflame the pancreas again and again, and some patients keep relapsing despite every standard drug. Daisuke Miura and co-authors describe a 39-year-old man who suffered six bouts of pancreatitis over nine years, with triglycerides peaking above 2,300 milligrams per deciliter despite statins, fibrates, and omega-3 oils. He also had poorly controlled diabetes and fatty liver disease with moderate scarring.
Doctors cautiously started semaglutide, a GLP-1 drug usually avoided after pancreatitis. His triglycerides settled near 213, he lost weight, his blood sugar and liver stiffness improved, and he came off insulin, with no new pancreatitis. The authors argue such drugs deserve consideration in carefully chosen patients when standard therapy fails.
Catalog record
| CREATOR | Daisuke Miura, Stephen Nicholls, Anju E Joham, Michael Braude, Chau Thien Tay |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |